Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats

BACKGROUND: Iron chelators are used to treat iron overload cardiomyopathy patients. However, a direct comparison of the benefits of three common iron chelators (deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX)) or an antioxidant (N-acetyl cysteine (NAC)) with a combined DFP and NAC treatm...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Wongjaikam, Suwakon, Kumfu, Sirinart, Khamseekaew, Juthamas, Sripetchwandee, Jirapas, Srichairatanakool, Somdet, Fucharoen, Suthat, Chattipakorn, Siriporn C., Chattipakorn, Nipon
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4948821/
https://ncbi.nlm.nih.gov/pubmed/27428732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0159414
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items